insights_auto
Why is PACB down 4.53%?
Dive Deeperchevron_right
PACB:NASDAQ
Pacific Biosciences of California Inc
$2.74
arrow_downward
-4.53%(-0.13) 1D
Oct 6, 11:20:52 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PACB...
Open
$3.02
High
$3.44
Low
$2.43
Mkt. cap
752.37M
Avg. vol.
11.99M
Volume
25.06M
52-wk high
$3.44
52-wk low
$1.07
EPS
-$0.43
Beta
2.19
Shares outstanding
310.83M
No. of employees
485
Open
$3.02
High
$3.44
Low
$2.43
Mkt. cap
752.37M
Avg. vol.
11.99M
Volume
25.06M
52-wk high
$3.44
52-wk low
$1.07
EPS
-$0.43
Beta
2.19
Shares outstanding
310.83M
No. of employees
485
News stories
From web sources and news partners
GuruFocus
·
43 minutes ago
PacBio (PACB) Partners with TychoBio to Advance RNA Therapy Deve
Benzinga
·
1 hour ago
Apogee Enterprises Posts Upbeat Q2 Earnings, Joins Constellation Energy, Freshworks And Other Big Stocks Moving Higher On Tuesday
Investing.com Canada
·
1 hour ago
PacBio partners with TychoBio on RNA therapy data generation By Investing.com
Yahoo Finance
·
2 hours ago
PacBio and TychoBio Collaborate to Train AI Models for Rare Disease RNA Therapeutics
Profile
Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing, based on the properties of zero-mode waveguides and sequencing by binding chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension. Wikipedia
About Pacific Biosciences of California Inc
CEOChristian Henry
Employees485
Founded2004
HeadquartersMenlo Park, California, United States
SectorHealth care
Websitepacb.com